Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative FLOT vs FOLFOX vs Chemoradiation for EGJ Adenocarcinoma
NCT03961841Phase 3Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jun 2020
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of fluorouracil, oxaliplatin, docetaxel in esophagogastric junction adenocarcinoma (GEJA), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
fluorouraciloxaliplatindocetaxel
03
Conditions
esophagogastric junction adenocarcinoma (GEJA)
Beyond the preview
Go deeper on NCT03961841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961841.